The role of pericytes in angiogenesis

International Journal of Developmental Biology

Volumn 55, Issue 3, 2011, Pages 261-268

  Ribatti, Domenico ^a   Nico, Beatrice ^a   Crivellato, Enrico ^b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Angiogenesis; Antiangiogenesis; Pericyte; Tumor growth

Indexed keywords

ANGIOPOIETIN; CELL PROTEIN; EPHRIN; EPHRIN RECEPTOR; IMATINIB; NOTCH RECEPTOR; NOTCH3 RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR ANTIBODY; PROTEIN ANG1; PROTEIN ANG2; PROTEIN ANTIBODY; PROTEIN NG2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; AUTOCRINE EFFECT; CELL ACTIVATION; CELL COUNT; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL STABILIZATION; CELL SURVIVAL; DRUG POTENTIATION; DRUG TARGETING; ENDOTHELIUM CELL; HUMAN; NONHUMAN; PARACRINE SIGNALING; PERICYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

CELL DIFFERENTIATION; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PERICYTES; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 79959400230     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.103167dr     Document Type: Review

References (89)

1. ABRAMSSON, A., LINDBLOM, P. and BETSHOLTZ, C. (2003). Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest 112: 1142-1151.
2. ADAMS, R.H., WILKINSON, G.A., WEISS, C., DIELLA, F., GALE, N.W., DEUTSCH, U., RISAU, W. and KLEIN, R. (1999). Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13: 295-306.
3. ALVA, J.A. and IRUELA-ARISPE, M.L. (2004). Notch signaling in vascular morphogenesis. Curr Opin Hematol 4: 278-283.
4. AMSELGRUBER, W.M., SCHAFER, M. and SINOWATZ, F. (1999). Angiogenesis in the bovine corpus luteum: an immunohistochemical and ultrastructural study. Anat Histol Embryol 28: 157-166.
5. BALUK, P., HASHIZUME, H. and MC DONALD, D.M. (2005). Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15: 102-111.
6. BARON, M., ASLAVM, H., FLASZA M., FOSTIER, M., HIGGS, J.E., MAZALEYRAT, S.L. and WILKIN, M.B. (2002). Multiple levels of Notch signal regulation (review). Mol Membr Biol 19: 27-38.
7. BENJAMIN, L.E., HEMO, I. and KESHET, E. (1998). A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125: 1591-1598.
8. BERGERS, G., SONG, S., MAYER-MORSE, N., BERGSLAND, E. and HANAHAN, D. (2003). Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111: 1287-1295.
9. BERGERS, G. and SONG, S. (2005). The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 7: 452-464.
10. BETSHOLTZ, C. (2004). Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev 15: 215-228.
11. BLOOD, C.H. and ZETTER, B.R. (1990). Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochem Biophys Acta 1032: 89-118.
12. BRATLEY-SIEDERS, D.M. and CHEN, J. (2004). Eph receptor tyrosine kinases in angiogenesis: from development to disease. Angiogenesis 7: 17-28.
13. CAI, J., KEHOE, O., SMITH, G.M., HYKIN, P. and BOULTON, M.E. (2008). The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy. Invest Ophthalmol Vis Sci 49: 2163-2171.
14. CAO, Y., SONVEAUX, P., LIU, S., ZHAO, Y., MI, J., CLARY, B.M., LI, C.Y., KONTOS, C.D. and DEWHIRST, M.W. (2007). Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth. Cancer Res 67: 3835-3844.
15. CLAXTON, S. and FRUTTIGER, M. (2004). Periodic Delta-like 4 expression in developing retinal arteries. Gene Expr Patterns 5: 123-127.
16. DARLAND, D.C. and D'AMORE, P.A. (2001). Cell-cell interactions in vascular development. Curr Top Dev Biol 52: 107-149.
17. DARLAND, D.C., MASSINGHAM, L.J., SMITH, S.R., SAINT-GENIEZ, M. and D'AMORE, P.A. (2003). Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev Biol 264: 275-288.
18. DE PALMA, M., VENNERI, M.A., GALLI, R., SERGI, L., POLITI, L.S., SAMPAOLESI, M. and NALDINI, L. (2005). Tie 2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8: 211-226.
19. DIAZ-FLORES, L., GUTIÉRREZ, R. and VARELA, H. (1992). Behavior and lineage of postcapillary venule pericytes during postnatal angiogenesis. J Morphol 213: 33-45.
20. FENG, Y., VOM HAGEN F., PFISTER, F., DjOKIC, S., HOFFMANN, S., BACK,W., WAGNER, P., LIN, J., DEUTSCH, U. and HAMMES, H.P. (2007). Impaired pericyte recruitment and abnormal retinal angiogenesis as a result of angiopoietin-2 overexpression. Thromb Haemost 97: 99-108.
21. FOO, S.S., TURNER, C.J., ADAMS, S., COMPAGNI, A., AUBYN, D., KOGATA, N., LINDBLOM, P., SHANI, M., ZICHA, D. and ADAMS, R.H. (2006). Ephrin-B2 controls cell motility and adhesion during blood-vessel wall assembly. Cell 124: 161-173.
22. FUKUSHI, J., MAKAGIANSAR, I.T. and STALLCUP, W.B. (2004). NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha 3 beta 1 integrin. Mol Biol Cell 15: 3580-3590.
23. GERETY, S.S., WANG, H.U., CHEN, Z.F. and ANDERSON, D.J. (1999). Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell 4: 403-414.
24. GERETY, S.S. and ANDERSON, D.J. (2002). Cardiovascular ephrinB2 is essential for embryonic angiogenesis. Development 129: 1397-1410.
25. GERHARDT, H. and BETSHOLTZ, C. (2003). Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314: 15-23.
26. GERHARDT, H. and SEMB, H. (2008). Pericytes: gatekeepers in tumor cell metastasis? J Mol Med 86: 135-144.
27. GREENBERG, J.I., SHIELDS, D.J., BARILLAS, S.G., ACEVEDO, L.M., MURPHY, E., HUANG, J., SCHEPPKE, L., STOCKMANN, C., JOHNSON, R.S., ANGLE, N. and CHERESH, D.A. (2008). A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 456: 809-813.
28. HAINSWORTH, J.D., SPIGEL, D.R., SOSMAN, J.A., BURRIS, H.A. 3rd, FARLEY, C., CUCULLU, H., YOST, K., HART, L.L., SYLVESTER, L., WATERHOUSE, D.M. and GRECO, F.A. (2007). Treatment of advanced renal cell carcinoma with the combination bevacizumab/erlotinib/imatinib: a phase I/II trial. Clin Genitourin Cancer 5: 427-432.
29. HASHIZUME, H., BALUK, P., MORIKAWA, S., MC LEAN, J.W., THURSTON, G., ROBERGE, S., JAIN, R.K. and MC DONALD, D.M. (2000). Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156: 1363-1380.
30. HELLSTROM, M., KALEN, M., LINDAHL, P., ABRAMSSON, A. and BETSHOLTZ, C. (1999) Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126: 3047-3055.
31. HOBBS, S.K., MONSKY, W.L., YUAN, F., ROBERTS, W.G., GRIFFITH, L., TORCHILIN, V.P. and JAIN, R.K. (1998). Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95: 4607-4612.
32. HUGHES, C.C. (2008). Endothelial-stromal interactions in angiogenesis. Curr Opin Hematol 15: 204-209.
33. INAI, T., MANCUSO, M., HASHIZUME, H., BAFFERT, F., HASKELL, A., BALUK, P., HU-LOWE, D.D., SHALINSKY, D.R., THURSTON, G., YANCOPOULOS, G.D. and MCDONALD, D.M. (2004). Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 165: 35-52.
34. ISO T., HAMAMORI, Y. and KEDES, L. (2003). Notch signaling in vascular development. Arterioscler Thromb Vasc Biol 23: 543-553.
35. JAIN, R.K. 2005. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307: 58-62.
36. JONES, N., ILJIN, K., DUMONT, D.J. and ALITALO, K. (2001). Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2: 257-267.
37. KASHIWAGI, S., IZUMI, Y., GOHONGI, T., DEMOU, Z.N., XU, L., HUANG, P.L., BUERK, D.G., MUNN, L.L., JAIN, R.K. and FUKUMURA, D. (2005). NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels. J Clin Invest 115: 181618-181627.
38. KUWABARA, T. and COGAN, D.G. (1963). Retinal vascular patterns. VI. Mural cells of the retinal capillaries. Arch Ophthalmol 69: 492-502.
39. LEBRIN, F., DECKERS, M., BERTOLINO, P. and TEN DIJKE, P. (2005). TGF-beta receptor function in the endothelium. Cardiovasc Res, 65: 599-608.
40. LEVEEN, P., PEKNY, M., GEBREMEDHIN, S., SWOLIN, B., LARSSON, E. and BETSHOLTZ, C. (1994). Mice deficient for PDGFB show renal, cardiovascular and hematological abnormalities. Genes Dev, 8: 1975-1987.
41. LI, D.Y., SORENSEN, L.K., BROOKE, B.S., URNESS, L.D., DAVIS, E.C., TAYLOR, D.G., BOAK, B.B. and WENDEL, D.P. (1999). Defective angiogenesis in mice lacking endoglin. Science 284: 1534-1537.
42. LINDBLOM, P., GERHARDT, H., LIEBNER, S., ABRAMSSON, A., ENGE, M., HELLSTROM, M., BACKSTROM, G., FREDRIKSSON, S., LANDEGREN, U., NYSTROM, H.C., BERGSTROM, G., DEJANA, E., OSTMAN, A., LINDAHL, P. and BETSHOLTZ, C., (2003). Endothelial PDGF-B retention is required for proper investment of pericyte in the microvessel wall. Genes Dev 17: 1935-1840.
43. LIU, H., KENNARD, S. and LILLY, B. (2009). NOTCH3 expression is induced in mural cells through an autoregulatory loop that requires endothelial-expressed JAGGED1. Cir Res 104: 466-475.
44. LOI, M., MARCHIO', S., BECHERINI, P., DI PAOLO, D., SOSTER, M., CURNIS, F., BRIGNOLE, C., PAGNAN, G., PERRI, P., CAFFA, I., LONGHI, R., NICO, B., BUSSOLINO, F., GAMBINI, C., RIBATTI, D., CILLI, N., ARAP, W., PASQUALINI, R., ALLEN, T.M., CORTI, A., PONZONI, M. and PASTORINO, F. (2010). Combined targeting of perivascular and endothelial tumor cells enhances antitumor efficacy of liposomal chemotherapy in neuroblastoma. J Control Release 145: 66-73.
45. LOUVI, A., ARBOLEDA-VELASQUEZ, J.F. and ARTAVANIST-SAKONAS, S. (2006). CADASIL: a critical look at a Notch disease. Dev Neurosci 28: 5-12.
46. LOVSCHALL, H., MITSIADIST, A., POULSEN, K., JENSEN, K.H. and KJELDSEN, A.L. (2007). Coexpression of Notch3 and Rgs5 in the pericyte-vascular smooth muscle cell axis in response to pulp injury. Int J Dev Biol 51: 715-721.
47. LU, C., SHAHZAD, M.M., MORENO-SMITH, M., LIN, Y.G., JENNINGS, N.B., ALLEN, J.K., LANDEN, C.N., MANGALA, L.S., ARMAIZ-PENA, G.N., SCHMANDT, R., NICK, A.M., STONE, R.L., JAGGE, R.B., COLEMAN, R.L. and SOOD, A.K. (2010). Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models. Cancer Biol Ther 9: 176-182.
48. MACIAG, P.C., SEAVEY, M.M., PAN, Z.K., FERRONE, S. and PATERSON, Y. (2008). Cancer immunotherapy targeting the high molecular weight melanomaassociated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature. Cancer Res 68: 8066-8075.
49. MAISONPIERRE, P.C., SURI, C., JONES, P.F., BARTUNKOVA, S., WIEGAND, S.J., RADZIEJWSKI, C., COMPTON, D., MCCLAIN, J., ALDRICH, T.H., PAPADOPOULOS, N., DALY, T.J., DAVIS, S., SATO, T.N. and YANCOPOULOS, G.D. (1997). Angiopoietin-2, a natural antagonist for Tie 2 that disrupts in vivo. angiogenesis. Science 277: 55-60.
50. MANCUSO, M.R., DAVIS, R., NORBERG, S.M., O'BRIEN, S., SENNINO, B., NAKAHARA, T., YAO, V.J., INAI, T., BROOKS, P., FREIMARK, B., SHALINSKY, D.R., HU-LOWE, D.D. and MCDONALD, D.M. (2006). Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest 116: 2610-2621.
51. MAYER, S. (1902). Die Muscularisierung der kapillaren Blutgefässe. Anat Anz 21: 442-455.
52. MORIKAWA, S., BALUK, P., KAIDOH, T., HASKELL, A., JAIN, R.K. and MCDONALD, D.M., (2002). Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160: 985-1000.
53. MURPHY, E.A., SHIELDS, D.J., STOLETOV, K., DNEPROVSKAIA, E., MCELROY, M., GREENBERG, J.I., LINDQUIST, J., ACEVEDO, L.M., ANAND, S., MAJETI, B.K., TSIGELNY, I., SALDANHA, A., WALSH, B., HOFFMAN, R.M., BOUVET, M., KLEMKE, R.L., VOGT, P.K., ARNOLD, L., WRASIDLO, W. and CHERESH, D.A. (2010). Disruption of angiogenesis and tumor growth with an orally active drug that stabilzes the inactive state of PDGFR?/B-RAF. Proc Natl Acad Sci USA 107: 4299-4304.
54. NEHLS, V., DENZER, K., DRENCKHAHN, D. (1992). Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res 270: 469-474.
55. NEHLS, V. and DRENCKHAHN, D. (1993). The versatily of microvascular pericytes: from mesenchyme to smooth muscle? Histochemistry 99: 1-12.
56. OHLSSON, R., FALCK, P., HELLSTROM, M., LINDAHL, P., BOSTROM, H., FRANKLIN, G., AHRLUND-RICHTER, L., POLLARD, J., SORIANO, P. and BESTSHOLTZ, C. (1999). PDGFB regulates the development of the labyrinthine layer of the mouse fetal placenta. Dev Biol 212: 124-136.
57. ORLIDGE, A. and D'AMORE, P.A. (1987). Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 105: 1455-1462.
58. OZERDEM, U. and STALLCUP, W.B. (2003). Early contribution of pericytes to angiogenic sprouting and tube formation. Angiogenesis 6: 241-249.
59. OZERDEM, U. and STALLCUP, W.B. (2004). Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. Angiogenesis 7: 269-276.
60. PATAN, S. (1998). TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth. Microvasc Res 56: 1-21.
61. PETRAS, K. and HANAHAN, D. (2005). A multitargeted, metronomic, and maximum- tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer. J Clin Oncol 23: 939-952.
62. RAJANTIE, I., ILMONEN, M., ALMINAITE, A., OZERDEM, U., ALITALO, K. and SALVEN, P. (2004). Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood, 104: 2084-2086.
63. REINMUTH, N., LIU, W., JUNG, Y.D., AHMAD, S.A., SHAHEEN, R.M., FAN, F., BUCANA, C.D., MCMAHON, G., GALLICK, G.E. and ELLIS, L.M. (2001). Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J 15: 1239-1241.
64. ROUGET, C. (1873). Mémoire sur le développment, la structure et les propertiés physiologiques des capillaries sanguins et lymphatiques. Arch Physiol Norm Pathol 5: 603-663.
65. ROUGET, C. (1874). Note sur le dévelopment de la tunique contractile des vaissaux. Compt Rend Acad Sci Paros 59: 559-562.
66. ROUGET, C. (1879). Sur la contractilité des capillaires sanguins. Compt Rend Acad Sci Paris 88: 916-918.
67. SALVUCCI, O., MARIC, D., ECONOMOPOLOU M., SAKAKIBARA, S., MERLIN, S., FOLLENZI, A. and TOSATO, G. (2009). Ephrin B reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood 114: 1707-1716.
68. SATO, Y. and RIFKIN, D.B. (1989). Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol 109: 309-315.
69. SCHLINGEMANN, R.O., RIETVELD, F.J., DE WALL, R.M., FERRONE, S. and RUITE, D.J. (1990). Expression of the high molecular weight melanomaassociated antigen by pericytes during angiogenesis in tumors and in healing wounds. Am J Pathol 136: 1393-1405
70. SENNINO, B., FALCON, B.L., MCCAULEY, D., LE, T., MCCAULEY, T., KURZ, J.C., HASKELL, A., EPSTEIN, D.M. and MCDONALD, D.M. (2007). Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of plateletderived growth factor B by selective aptamer AX102. Cancer Res 67: 7358-7367.
71. SHAHEEN, R.M., TSENG, W.W., DAVIS, D.W., LIU, W., REINMUTH, N., VELLAGAS, R., WIECZOREK, A.A., OGURA, Y., MCCONKEY, D.J., DRAZAN, K.E., BUCANA, C.D., MCMAHON, G. and ELLIS, L.M. (2001). Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanism. Cancer Res 61: 1464-1468.
72. + perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol 7: 870-879.
73. STRATMAN, A.N., MALOTTE, K.M., MAHAN, R.D., DAVIS, M.J. and DAVIS, G.E. (2009). Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 114: 5091-5101.
74. SUNDBERG, C., KOWANETZ, M., BROWN, L.F., DETMAR, M. AND DVORAK, H.F. (2002). Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab Invest 82: 387-401.
75. THURSTON, G., SURI, C., SMITH, K., MC CLAIN, J., SATO, T.N., YANCOPOULOS, G.D. and MC DONALD, D.M. (1999). Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286: 2511-2514.
76. THURSTON, G. (2003). Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res 314: 61-68.
77. TONG, R.T., BOUCHER, Y., KOZIN, S.V., WINKLER, F., HICKLIN, D.J. and JAIN, R.K., (2004). Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 64: 3731-3736.
78. UEMURA, A., OGAWA, M., HIRASHIMA, M., FUJIWARA, T., KOYAMA, S., TAKAGI, H., HONDA, Y., WIEGAND, S.J., YANCOPOULOS, G.D. and NISHIKAWA, S. (2002). Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest 110: 1615-1817.
79. VIMTRUP, B.J. (1922). Beitrage zur Anatomie der kapillaren. Ubër contractile Elemente in der Gefäβwand der Blutcapillaren. Zeitschr Anat Entwickl 45: 392-399.
80. VIRGINTINO, D., GIROLAMO, F., ERREDE, M., CAPOBIANCO, C., ROBERTSON, D., STALLCUP, W.D., PERRIS, R. and RONCALI, L. (2007). An intimate interplay between precocius, migrating pericytes and endothelial cells govern human fetal brain angiogenesis. Angiogenesis 10: 35-45.
81. VON TELL, D., ARMULIK, A. and BETSHOLTZ. C. (2006). Pericytes and vascular stability. Exp Cell Res 312: 623-629.
82. WAKUI, S., YOKOO, K., MUTO, T., SUZUKI, Y., TAKAHASHI, M., FURUSATO, M., HANO, H., ENDOU, H. and KANAI, Y. (2006). Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis. Lab Invest 86: 1172-1184.
83. WANG, H., CHEN, Z. and ANDERSON, D. (1998). Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93: 741-753.
84. WANG, T., BARON, M. and TRUMP, D. (2007). An overview of Notch 3 function in vascular smooth muscle cells. Prog Biophys Mol Biol 96: 499-509.
85. WESSELING, P., SCHLINGEMANN, R.O., RIETVELD, F.J., LINK, M., BURGER, P.C. and RUITER, D.J. (1995) Early and extensive contribution of pericytes/ vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immuno-light and immuno-electron microscopic study. J Neuropathol Exp Neurol 54: 304-310.
86. WILLETT, C.G., BOUCHER, Y., DI TOMASO, E., DUDA, D.G., MUNN, L.L., TONG, R.T., CHUNG, D.C., SAHANI, D.V., KALVA, S.P., KOZIN, S.V., MINO, M., COHEN, K.S., SCADDEN, D.T., HARTFORD, A.C., FISCHMAN, A.J., CLARK, J.W., RYAN, D.P., ZHU, A.X., BLASZKOWSKY, L.S., CHEN, H.X., SHELLITO, P.C., LAUWERS, G.Y. and JAIN, R.K. (2004). Direct evidence that the VEGFspecific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10: 145-147.
87. YAMAGISHI, S., YONEKURA, H., YAMAMOTO, Y., FUJIMORI, H., SAKURAI, S., TANAKA, N. and YAMAMOTO, H. (1999). Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. Lab Invest 79: 501-509.
88. ZHANG, L., YANG, N., PARK, J.W., KATSAROS, D., FRACCHIOLI, S., CAO, G., O'BRIENJENKINS, A., RANDALL, T.C., RUBIN, S.C., COUKOS, G. (2003). Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res 63: 3403-3412.
89. ZIMMERMANN, K.W. (1923). Der feinere Bau der Blutkapillaren. Z Anat Entwick 68: 29-36.